...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Further optimization of the M-1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration
【24h】

Further optimization of the M-1 PAM VU0453595: Discovery of novel heterobicyclic core motifs with improved CNS penetration

机译:M-1 PAM的进一步优化VU0453595:发现具有改进的CNS渗透性的新型杂环双环核心基序

获取原文
获取原文并翻译 | 示例
           

摘要

This Letter describes the continued chemical optimization of the VU0453595 series of M-1 positive allosteric modulators (PAMs). By surveying alternative 5,6- and 6,6-heterobicylic cores for the 6,7-dihy-dro-5H-pyrrolo[3,4-b]pyridine-5-one core of VU453595, we found new cores that engendered not only comparable or improved M-1 PAM potency, but significantly improved CNS distribution (K(p)s 0.3-3.1). Moreover, this campaign provided fundamentally distinct M-1 PAM chemotypes, greatly expanding the available structural diversity for this valuable CNS target, devoid of hydrogen-bond donors. (C) 2016 Elsevier Ltd. All rights reserved.
机译:该信函描述了VU0453595系列M-1阳性变构调节剂(PAM)的持续化学优化。通过调查VU453595的6,7-二氢-dro-5H-吡咯并[3,4-b]吡啶-5核的替代5,6-和6,6-异核核,我们发现没有产生的新核仅可比或改善M-1 PAM效能,但显着改善CNS分布(K(p)s 0.3-3.1)。此外,这项运动从根本上提供了独特的M-1 PAM化学型,极大地扩展了这一宝贵的中枢神经系统靶标的可用结构多样性,而没有氢键供体。 (C)2016 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号